Is there a generic for Tubocurarine chloride?

The FDA Orange Book does not currently list an approved generic (ANDA) for Tubocurarine chloride. It is available as 3 brand (NDA) applications.

What is the reference-listed drug for Tubocurarine chloride?

TUBOCURARINE CHLORIDE (NDA 005657, BRISTOL MYERS SQUIBB) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Tubocurarine chloride are approved?

Tubocurarine chloride is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Tubocurarine chloride

Tubocurarine chloride is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TUBOCURARINE CHLORIDE · NDA 005657

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
TUBOCURARINE CHLORIDE	BRISTOL MYERS SQUIBB	NDA 005657	—	Approved Prior to Jan 1, 1982
TUBOCURARINE CHLORIDE	HOSPIRA	NDA 006095	—	Approved Prior to Jan 1, 1982
TUBOCURARINE CHLORIDE	LILLY	NDA 006325	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Tubocurarine chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo